Begin main content

Call for Feedback: Drugs for Type 2 Diabetes: Second- and Third-Line Therapy Review Update

August 22, 2017
A draft report on Drugs for Type 2 Diabetes: Second- and Third-Line Therapy Review Update is now available for feedback from all interested stakeholders. Project Call for Feedback Feedback Due By Drugs for Type 2 Diabetes: Second- and Third-Line Therapy Review Update 2017-08-22 2017-09-06 Consultation Document Product Type Submit Stakeholder Fee...

Call for Feedback: Dental Amalgams Compared With Resin Composites

August 21, 2017
A draft report on Dental Amalgams Compared With Resin Composites is now available for feedback from all interested stakeholders. Project Call for Feedback Feedback Due By Dental Amalgams Compared With Resin Composites 2017-08-21 2017-09-05 Consultation Document Product Type Submit Stakeholder Feedback List of Included Studies Health Technology A...

Call for Patient Input: Dupixent

August 15, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Dupixent Brand name Generic name Manufacturer ...

CDR Update 126

August 14, 2017
See CDR Update 126 for important news and information regarding the CADTH Common Drug Review.

New Members Join CADTH Board of Directors

August 10, 2017
CADTH is pleased to announce the election of four new members to its Board of Directors effective July 11, 2017: John Abbott, Jurisdictional (Atlantic Provinces) Mitch Moneo, Jurisdictional (Western Provinces) Ellen Pekilis, Public Dr. Charmaine Roye, Health System. The CADTH Board of Directors has overall responsibility for administering the af...